Phase I Trial of BMN 673 and Selected Cytotoxics in Patients With Advanced Solid Tumors
Latest Information Update: 28 Sep 2022
At a glance
- Drugs Talazoparib (Primary) ; Irinotecan; Temozolomide
- Indications Cancer metastases; Solid tumours
- Focus Adverse reactions
- 22 Sep 2022 Results published in the Clinical Cancer Research
- 07 Nov 2019 Status changed from active, no longer recruiting to completed.
- 08 Aug 2019 Planned End Date changed from 30 Jun 2019 to 30 Sep 2020.